221 related articles for article (PubMed ID: 28587542)
1. Evaluation of cerebral glioma using 3T diffusion kurtosis tensor imaging and the relationship between diffusion kurtosis metrics and tumor cellularity.
Qi C; Yang S; Meng L; Chen H; Li Z; Wang S; Jiang T; Li S
J Int Med Res; 2017 Aug; 45(4):1347-1358. PubMed ID: 28587542
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study.
Hempel JM; Schittenhelm J; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
Eur J Radiol; 2017 Oct; 95():202-211. PubMed ID: 28987669
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
[TBL] [Abstract][Full Text] [Related]
6. Gliomas: diffusion kurtosis MR imaging in grading.
Van Cauter S; Veraart J; Sijbers J; Peeters RR; Himmelreich U; De Keyzer F; Van Gool SW; Van Calenbergh F; De Vleeschouwer S; Van Hecke W; Sunaert S
Radiology; 2012 May; 263(2):492-501. PubMed ID: 22403168
[TBL] [Abstract][Full Text] [Related]
7. Characterization of clear cell renal cell carcinoma with diffusion kurtosis imaging: correlation between diffusion kurtosis parameters and tumor cellularity.
Dai Y; Yao Q; Wu G; Wu D; Wu L; Zhu L; Xue R; Xu J
NMR Biomed; 2016 Jul; 29(7):873-81. PubMed ID: 27119793
[TBL] [Abstract][Full Text] [Related]
8. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis of the patients with high-grade gliomas.
Wang X; Gao W; Li F; Shi W; Li H; Zeng Q
Magn Reson Imaging; 2019 Nov; 63():131-136. PubMed ID: 31425809
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of histopathological changes in the microstructure at the center and periphery of glioma tumors using diffusional kurtosis imaging.
Li F; Shi W; Wang D; Xu Y; Li H; He J; Zeng Q
Clin Neurol Neurosurg; 2016 Dec; 151():120-127. PubMed ID: 27825037
[TBL] [Abstract][Full Text] [Related]
10. Grading and proliferation assessment of diffuse astrocytic tumors with monoexponential, biexponential, and stretched-exponential diffusion-weighted imaging and diffusion kurtosis imaging.
Zhang J; Chen X; Chen D; Wang Z; Li S; Zhu W
Eur J Radiol; 2018 Dec; 109():188-195. PubMed ID: 30527302
[TBL] [Abstract][Full Text] [Related]
11. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.
Jiang R; Jiang J; Zhao L; Zhang J; Zhang S; Yao Y; Yang S; Shi J; Shen N; Su C; Zhang J; Zhu W
Oncotarget; 2015 Dec; 6(39):42380-93. PubMed ID: 26544514
[TBL] [Abstract][Full Text] [Related]
12. In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.
Hempel JM; Schittenhelm J; Bisdas S; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
J Neuroradiol; 2018 Feb; 45(1):32-40. PubMed ID: 28865921
[TBL] [Abstract][Full Text] [Related]
13. Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.
Pang H; Ren Y; Dang X; Feng X; Yao Z; Wu J; Yao C; Di N; Ghinda DC; Zhang Y
J Magn Reson Imaging; 2016 Jul; 44(1):30-40. PubMed ID: 26588793
[TBL] [Abstract][Full Text] [Related]
14. Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.
Li S; Zheng Y; Sun W; Lasič S; Szczepankiewicz F; Wei Q; Han S; Zhang S; Zhong X; Wang L; Li H; Cai Y; Xu D; Li Z; He Q; van Westen D; Bryskhe K; Topgaard D; Xu H
Eur Radiol; 2021 Nov; 31(11):8197-8207. PubMed ID: 33914116
[TBL] [Abstract][Full Text] [Related]
15. A correlation between diffusion kurtosis imaging and the proliferative activity of brain glioma.
Tonoyan AS; Pronin IN; Pitshelauri DI; Shishkina LV; Fadeeva LM; Pogosbekyan EL; Zakharova NE; Shults EI; Khachanova NV; Kornienko VN; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2015; 79(6):5-14. PubMed ID: 26977789
[TBL] [Abstract][Full Text] [Related]
16. Value of diffusion kurtosis imaging in assessing low-grade gliomas.
Goryawala MZ; Heros DO; Komotar RJ; Sheriff S; Saraf-Lavi E; Maudsley AA
J Magn Reson Imaging; 2018 Dec; 48(6):1551-1558. PubMed ID: 29573042
[TBL] [Abstract][Full Text] [Related]
17. Analysis of diffusion tensor imaging metrics for gliomas grading at 3 T.
Server A; Graff BA; Josefsen R; Orheim TE; Schellhorn T; Nordhøy W; Nakstad PH
Eur J Radiol; 2014 Mar; 83(3):e156-65. PubMed ID: 24457139
[TBL] [Abstract][Full Text] [Related]
18. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging.
Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M
Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975
[TBL] [Abstract][Full Text] [Related]
19. The role of MR diffusion kurtosis and neurite orientation dispersion and density imaging in evaluating gliomas.
Genç B; Aslan K; Özçağlayan A; İncesu L
J Neuroimaging; 2023; 33(4):644-651. PubMed ID: 37170070
[TBL] [Abstract][Full Text] [Related]
20. Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades.
Zhu J; Luo X; Gao J; Li S; Li C; Chen M
Cancer Imaging; 2021 Mar; 21(1):30. PubMed ID: 33726862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
